DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 7.695
EU - Europa 3.724
AS - Asia 3.156
SA - Sud America 470
AF - Africa 51
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 15.116
Nazione #
US - Stati Uniti d'America 7.613
PL - Polonia 1.343
CN - Cina 1.201
SG - Singapore 1.013
UA - Ucraina 642
DE - Germania 448
BR - Brasile 399
HK - Hong Kong 362
IT - Italia 346
FI - Finlandia 208
GB - Regno Unito 206
VN - Vietnam 157
RU - Federazione Russa 127
IE - Irlanda 108
TR - Turchia 107
FR - Francia 106
IN - India 102
BD - Bangladesh 54
CA - Canada 44
ES - Italia 36
CZ - Repubblica Ceca 33
ID - Indonesia 33
AR - Argentina 32
MX - Messico 29
SE - Svezia 29
NL - Olanda 26
BE - Belgio 25
JP - Giappone 22
ZA - Sudafrica 20
EC - Ecuador 11
MA - Marocco 11
IQ - Iraq 10
PK - Pakistan 10
SA - Arabia Saudita 10
TW - Taiwan 10
AT - Austria 9
AU - Australia 9
CO - Colombia 9
EU - Europa 9
IR - Iran 9
KR - Corea 8
VE - Venezuela 8
CH - Svizzera 7
AZ - Azerbaigian 6
LT - Lituania 6
UZ - Uzbekistan 6
IL - Israele 5
KZ - Kazakistan 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
JO - Giordania 4
KG - Kirghizistan 4
PY - Paraguay 4
BG - Bulgaria 3
BO - Bolivia 3
EG - Egitto 3
NO - Norvegia 3
PT - Portogallo 3
SD - Sudan 3
TN - Tunisia 3
CL - Cile 2
HN - Honduras 2
KE - Kenya 2
LB - Libano 2
MD - Moldavia 2
MU - Mauritius 2
MY - Malesia 2
PA - Panama 2
AL - Albania 1
BB - Barbados 1
BH - Bahrain 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PW - Palau 1
RO - Romania 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
UY - Uruguay 1
Totale 15.116
Città #
Warsaw 1.338
Fairfield 1.025
Woodbridge 797
Ashburn 674
Houston 500
Jacksonville 475
Singapore 465
Cambridge 412
Seattle 400
Ann Arbor 394
Wilmington 369
Hong Kong 351
Chandler 288
Beijing 243
Princeton 201
Nanjing 170
New York 131
Helsinki 116
Los Angeles 114
Dublin 107
Brescia 101
Dearborn 95
The Dalles 92
Chicago 90
Dallas 90
Istanbul 85
Munich 72
Dong Ket 62
Moscow 60
Buffalo 59
Changsha 58
Nanchang 53
San Francisco 51
Shanghai 51
São Paulo 45
Milan 44
Shenyang 43
Jinan 41
Des Moines 39
San Diego 37
Hebei 36
Lancaster 35
Redondo Beach 35
Ho Chi Minh City 34
Tianjin 33
Jiaxing 32
Hangzhou 27
Phoenix 27
Brussels 25
Boardman 24
Brooklyn 23
Jakarta 22
Kunming 22
London 22
San Mateo 21
Santa Clara 21
Taizhou 20
Tampa 20
Brno 19
Salt Lake City 19
Tokyo 19
Hanoi 18
Ningbo 18
Lanzhou 17
Chennai 16
Augusta 15
Elk Grove Village 15
Leawood 15
Manchester 15
Stockholm 15
Vieste 15
Denver 14
Olomouc 14
Guangzhou 13
Haikou 13
Montreal 13
Toronto 13
Turku 13
Belo Horizonte 12
Poplar 12
Seveso 12
Zhengzhou 12
Atlanta 11
Barcelona 11
Boston 11
Brasília 11
Fuzhou 11
Verona 11
Mexico City 10
Norwalk 10
Orem 10
Ankara 9
Porto Alegre 9
Walnut 9
Amsterdam 8
Bologna 8
Charlotte 8
Dhaka 8
Falkenstein 8
Kansas City 8
Totale 10.845
Nome #
Comparative analysis of mesenchymal stromal cells biological properties 330
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 309
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 298
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 292
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 284
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 284
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 276
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 269
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 254
Clinical potentials of human pluripotent stem cells 253
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 243
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 237
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 228
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 218
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 214
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 197
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 197
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 195
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 194
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 193
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 187
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 179
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 179
MEMS force microactuator with displacement sensing for mechanobiology experiments 179
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 175
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 171
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 169
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 169
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 167
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 164
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 163
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 162
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 161
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 158
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 157
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 156
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 155
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 153
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 153
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 149
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 147
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 147
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 146
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 145
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 145
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 145
Using iPS cells toward the understanding of parkinson'€™s disease 142
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 139
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 139
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 139
iPS, organoids and 3D models as advanced tools for in vitro toxicology 137
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 136
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 135
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 132
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 131
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 129
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 129
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 128
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 128
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 127
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 127
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 127
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 125
iPS technology as a tool to investigate atrial fibrillation. 125
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 125
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 123
Fibroblast growth factor-2 in angiogenesis 122
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 122
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 121
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 121
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 120
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 119
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 118
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 115
Atrial fibrillation modeling with iPSC derived cardiomyocyte 115
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 114
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 113
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 113
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 112
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 110
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 109
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 104
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 103
Preliminary report: hiPSC reprogramming and karyotypic studies 103
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 102
hiPSC reprogramming and karyotypic alterations: a brief report 99
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 99
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 98
iPS technology as a tool to investigate atrial fibrillation 96
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 93
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 93
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 92
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 91
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 90
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 83
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 81
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 77
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 70
Fat-derived mesenchymal stromal cells: different sources, different properties 67
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 61
Totale 15.215
Categoria #
all - tutte 61.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.235 0 0 0 0 0 172 108 214 235 174 211 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/20252.047 26 19 5 280 180 185 158 48 266 132 521 227
2025/20262.277 394 471 303 519 545 45 0 0 0 0 0 0
Totale 15.370